FiberCel Viable Bone Matrix Associated With Tuberculosis
On June 2, 2021, the FDA issued an “Urgent Voluntary Notification: FiberCel Fiber Viable Bone Matrix (“FiberCel”) – Lot Number: NMDS210011” stating: “Aziyo Biologics, Inc., (“Aziyo”) is the manufacturer of record for FiberCel Fiber Viable Bone Matrix (“FiberCel”) [...]